Cargando…
Dyslipidemia in Transplant Patients: Which Therapy?
Cardiovascular disease is the most important cause of death worldwide in recent years; an increasing trend is also shown in organ transplant patients subjected to immunosuppressive therapies, in which cardiovascular diseases represent one of the most frequent causes of long-term mortality. This is a...
Autores principales: | Iannuzzo, Gabriella, Cuomo, Gianluigi, Di Lorenzo, Anna, Tripaldella, Maria, Mallardo, Vania, Iaccarino Idelson, Paola, Sagnelli, Caterina, Sica, Antonello, Creta, Massimiliano, Baltar, Javier, Crocetto, Felice, Bresciani, Alessandro, Gentile, Marco, Calogero, Armando, Giallauria, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318180/ https://www.ncbi.nlm.nih.gov/pubmed/35887846 http://dx.doi.org/10.3390/jcm11144080 |
Ejemplares similares
-
Epidemiological and clinical aspects of hepatitis B virus infection in Italy over the last 50 years
por: Sagnelli, Caterina, et al.
Publicado: (2022) -
Renal involvement in COVID-19: focus on kidney transplant sector
por: Sagnelli, Caterina, et al.
Publicado: (2021) -
Inhibitors of Protein Convertase Subtilisin/Kexin 9 (PCSK9) and Acute Coronary Syndrome (ACS): The State-of-the-Art
por: Iannuzzo, Gabriella, et al.
Publicado: (2021) -
How Fear of COVID-19 Can Affect Treatment Choices for Anaplastic Large Cell Lymphomas ALK+ Therapy: A Case Report
por: Sica, Antonello, et al.
Publicado: (2021) -
Does Physical Activity Regulate Prostate Carcinogenesis and Prostate Cancer Outcomes? A Narrative Review
por: Capece, Marco, et al.
Publicado: (2020)